American College of Clinical Pharmacy
      Search      Cart
         

SCHEDULE

Mythbusters: Debunking Myths and Misconceptions in Pharmacy Practice​

Sunday, October 18, 2026 from 10:30 a.m. to 12:00 p.m. MDT at Salt Palace Convention Center - Ballroom I

Available for 1.50 hours of CPE credit
Activity Type: An Application-Based Activity

Pharmacy practice is filled with long-held beliefs and practices that, while widely accepted, may not always be supported by current evidence. In this interactive session, we will uncover the truth behind common myths and misconceptions in clinical pharmacy by introducing prevalent myths related to alcohol use disorder treatment, antibiotic selection, and QTc prolongation, then critically reviewing the supporting and opposing literature, and applying evidence-based findings to patient case scenarios. Through a combination of presentations and case-based discussions, attendees will actively engage in evaluating clinical practices, questioning assumptions, and developing strategies to educate colleagues and patients effectively. By the end of the session, participants will be equipped with the skills to integrate the most accurate and up-to-date information into their daily practice to ensure optimal patient care. 

Learning Objectives

1. Evaluate the safety and efficacy of naltrexone in patients with liver disease to guide appropriate, evidencebased prescribing. 

2. Address the routine use of vitamin supplementation in patients with alcohol use disorder. 

3. Explain the clinical significance of the cefazolin inoculum effect. 

4. Differentiate between patient populations with MSSA infections who may benefit from cefazolin versus antistaphylococcal penicillins.

5. Evaluate the limitations of automated QTc measurement. 

6. Examine the role of implanted cardiac devices in mitigating the risk of torsades de pointes and other QT-related arrhythmias. 

Emmeline Tran, Pharm.D., BCPS
Moderator:Emmeline Tran, Pharm.D., BCPS

AUDiting Our Assumptions: Rethinking Alcohol Use Disorder (AUD) Treatment

10:30 a.m. to 11:00 a.m.
Sarah T. Thomason, Pharm.D., BCACP
Speaker:Sarah T. Thomason, Pharm.D., BCACP
Chair and Professor, East Tennessee State University
Johnson City, TN
  View Biography

Deep-Seated Dilemmas: Resolving the Beta-Lactam Conundrum in Methicillin-Susceptible Staphylococcus aureus Infections

11:00 a.m. to 11:30 a.m.
Vanthida Huang, Pharm.D., FCCP
Speaker:Vanthida Huang, Pharm.D., FCCP
Professor of Pharmacy Practice/Veterinary Medicine/Biomedical Sciences, Director of Infectious Disease Fellowship, Midwestern University College of Pharmacy-Glendale Campus, Glendale, Arizona
  View Biography

Correcting the Correction: Pitfalls in QTc Interpretation and Management

11:30 a.m. to 12:00 p.m.
John R. Carr, Pharm.D., BCCCP, BCPS
Speaker:John R. Carr, Pharm.D., BCCCP, BCPS

Cookies

This website uses cookies to help ACCP provide you with the best user experience. If you continue to use our services, ACCP will assume that you agree to the use of such cookies. You can find out how to update your settings by referring to ACCP’s Policy on Cookies.